SEC
SlamSEC
SearchBrowseEarnings

Apogee Therapeutics, Inc.

Nasdaq:APGE
Biological Products, (No Diagnostic Substances)·WALTHAM, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(233 total)

TypeDateAccessionPeriodSize
SCHEDULE 13G
Mar 6, 2026
0001897612-26-000311
—
9.1 KB
4
Mar 6, 2026
0001104659-26-024831OWNERSHIP DOCUMENT
Mar 4, 2026
13.0 KB
4
Mar 4, 2026
0001104659-26-023651OWNERSHIP DOCUMENT
Mar 2, 2026
11.1 KB
S-8
Mar 2, 2026
0001104659-26-021900FORM S-8
—
197.6 KB
10-K
Mar 2, 2026
0001974640-26-00000210-K
Dec 31, 2025
15.0 MB
8-K
Mar 2, 2026
0001974640-26-0000018-K
Mar 2, 2026
448.6 KB
SCHEDULE 13G/A
Feb 17, 2026
0001493215-26-000028
—
10.3 KB
4
Feb 13, 2026
0001104659-26-015453OWNERSHIP DOCUMENT
Feb 11, 2026
9.2 KB
144
Feb 11, 2026
0001949846-26-000059
—
6.3 KB
SCHEDULE 13G/A
Feb 10, 2026
0000902219-26-000095
—
16.9 KB
4
Feb 4, 2026
0001104659-26-010454OWNERSHIP DOCUMENT
Feb 4, 2026
16.9 KB
4
Feb 4, 2026
0001104659-26-010453OWNERSHIP DOCUMENT
Feb 2, 2026
8.8 KB
SCHEDULE 13G
Jan 30, 2026
0000102909-26-000084
—
6.9 KB
4
Jan 22, 2026
0001104659-26-005921OWNERSHIP DOCUMENT
Jan 22, 2026
13.9 KB
144
Jan 22, 2026
0001104659-26-005918
—
4.8 KB
SCHEDULE 13D/A
Jan 22, 2026
0001104659-26-005916
—
18.0 KB
4
Jan 16, 2026
0001104659-26-004659OWNERSHIP DOCUMENT
Jan 14, 2026
15.0 KB
4
Jan 9, 2026
0001104659-26-002574OWNERSHIP DOCUMENT
Jan 7, 2026
15.0 KB
144
Jan 7, 2026
0001950047-26-000250
—
7.8 KB
4
Jan 6, 2026
0001104659-26-001485OWNERSHIP DOCUMENT
Jan 2, 2026
5.6 KB
4
Jan 6, 2026
0001104659-26-001484OWNERSHIP DOCUMENT
Jan 2, 2026
5.6 KB
4
Jan 6, 2026
0001104659-26-001483OWNERSHIP DOCUMENT
Jan 2, 2026
11.2 KB
8-K
Jan 6, 2026
0001104659-26-001063FORM 8-K
Jan 6, 2026
5.6 MB
144
Jan 2, 2026
0001950047-26-000068
—
8.3 KB
4
Dec 23, 2025
0001104659-25-124354OWNERSHIP DOCUMENT
Dec 19, 2025
4.9 KB
25 filings shown
CEO
Henderson Michael Thomas
CFO
Henderson Jane